Global Trust Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Global Trust Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20	Closed	-$3.38K	–	482
2026 Q1	$3.38K	Sell	20 -570	-97%	-$97.5K	﹤0.01%	406
2025 Q4	$99.6K	Buy	+590	New	+$95.8K	0.04%	201
2021 Q4	–	Sell	-3,301	Closed	-$534K	–	425
2021 Q3	$534K	Buy	3,301 +1,601	+94%	+$269K	0.24%	93
2021 Q2	$278K	Buy	+1,700	New	+$262K	0.13%	145
2020 Q1	–	Sell	-1,900	Closed	-$229K	–	379
2019 Q4	$229K	Buy	+1,900	New	+$212K	0.14%	149
2019 Q3	–	Sell	-32,340	Closed	-$32K	–	404
2019 Q2	$32K	Buy	32,340 +32,304	+89,733%	+$3.44M	0.02%	242
2019 Q1	$4K	Hold	36	–	–	﹤0.01%	304
2018 Q4	$3K	Hold	36	–	–	﹤0.01%	331
2018 Q3	$4K	Hold	36	–	–	﹤0.01%	353
2018 Q2	$4K	Hold	36	–	–	﹤0.01%	345
2018 Q1	$4K	Sell	36 -39	-52%	-$4.32K	﹤0.01%	331
2017 Q4	$8K	Buy	+75	New	+$8.02K	0.01%	317

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Global Trust Asset Management's IBB Position: Q2 2026 in Review

Global Trust Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 20 shares — an estimated $3.38K sold.

Global Trust Asset Management first reported a position in IBB in Q4 2017 and held it in 12 quarters. The position peaked at $534K in Q3 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Global Trust Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
Global Trust Asset Management sold 20 iShares Biotechnology ETF shares in Q2 2026, an estimated $3.38K.
Global Trust Asset Management first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 12 quarters.
Global Trust Asset Management's iShares Biotechnology ETF position peaked at $534K in Q3 2021.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.